☰

Joel A. Yates, Ph.D. - Publications

Affiliations: 
2011 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Biochemistry
Tree Info Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kumaraswamy A, Duan Z, Flores D, Zhang C, Sehrawat A, Hu YM, Swaim OA, Rodansky E, Storck WK, Kuleape JA, Bedi K, Mannan R, Wang XM, Udager AM, Ravikumar V, ... ... Yates JA, et al. LSD1 promotes prostate cancer cell reprogramming by repressing TP53 signaling independently of its demethylase function. Jci Insight. PMID 37440313 DOI: 10.1172/jci.insight.167440  0.32
2022 Storck WK, May AM, Westbrook TC, Duan Z, Morrissey C, Yates JA, Alumkal JJ. The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity. Frontiers in Endocrinology. 13: 926585. PMID 35909568 DOI: 10.3389/fendo.2022.926585  0.301
2020 Coleman DJ, Sampson DA, Sehrawat A, Kumaraswamy A, Sun D, Wang Y, Schwartzman J, Urrutia J, Lee AR, Coleman IM, Nelson PS, Dong X, Morrissey C, Corey E, Xia Z, ... Yates JA, et al. Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4. Neoplasia (New York, N.Y.). 22: 253-262. PMID 32403054 DOI: 10.1016/J.Neo.2020.04.002  0.394
2019 Altemus MA, Goo LE, Little AC, Yates JA, Cheriyan HG, Wu ZF, Merajver SD. Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes. Plos One. 14: e0220973. PMID 31536495 DOI: 10.1371/Journal.Pone.0220973  0.381
2019 Little AC, Pathanjeli P, Wu Z, Bao L, Goo LE, Yates JA, Oliver CR, Soellner MB, Merajver SD. IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling. Frontiers in Oncology. 9: 456. PMID 31214501 DOI: 10.3389/Fonc.2019.00456  0.378
2019 Goo LE, Yates JA, Little AC, Kremer D, Kovalenko I, Oliver CR, Westerhof T, Wu Z, Vandecan N, Bao L, Ulintz PJ, Lyssiotis CA, Merajver SD. Abstract 4363: Effects of the small GTPase RhoC on inflammatory breast cancer metabolism Cancer Research. 79: 4363-4363. DOI: 10.1158/1538-7445.Sabcs18-4363  0.41
2018 Cheriyan H, Wu Z, Yates J, Merajver SD. Abstract 5156: RhoC decreases tight junction stabilization in breast cancer cells, revealing a potential therapeutic target Cancer Research. 78: 5156-5156. DOI: 10.1158/1538-7445.Am2018-5156  0.371
2018 Goo LE, Yates JA, Bao L, Wu Z, Merajver SD. Abstract 1444: RhoC regulation of inflammatory breast cancer metabolism Cancer Research. 78: 1444-1444. DOI: 10.1158/1538-7445.Am2018-1444  0.402
2016 Allen SG, Chen YC, Madden JM, Fournier CL, Altemus MA, Hiziroglu AB, Cheng YH, Wu ZF, Bao L, Yates JA, Yoon E, Merajver SD. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling. Scientific Reports. 6: 39190. PMID 27991524 DOI: 10.1038/Srep39190  0.371
2016 Wynn ML, Yates JA, Evans CR, Van Wassenhove L, Wu ZF, Bridges S, Bao L, Fournier C, Ashrafzadeh S, Merrins MJ, Satin LS, Schnell S, Burant CF, Merajver SD. RhoC is a Potent Regulator of Glutamine Metabolism and N-acetylaspartate Production in Inflammatory Breast Cancer Cells. The Journal of Biological Chemistry. PMID 27129239 DOI: 10.1074/Jbc.M115.703959  0.353
2016 Yates JA, Altemus M, Wu Z, Wynn ML, Merajver SD. Abstract 1040: Differential levels of glycogen in breast cancer cell lines: A potential new target Cancer Research. 76: 1040-1040. DOI: 10.1158/1538-7445.Am2016-1040  0.378
2015 Yates JA, Wynn ML, Wu Z, Evans CR, Burant C, Schnell SD, Merajver SD. Abstract 1203: Metastasis-associated oncogene RhoC as a regulator of glutamine metabolism in the inflammatory breast cancer cell line SUM149 Cancer Research. 75: 1203-1203. DOI: 10.1158/1538-7445.Am2015-1203  0.385
2010 Menon T, Yates JA, Bochar DA. Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8. Molecular Endocrinology (Baltimore, Md.). 24: 1165-74. PMID 20308527 DOI: 10.1210/Me.2009-0421  0.607
2010 Yates JA, Menon T, Thompson BA, Bochar DA. Regulation of HOXA2 gene expression by the ATP-dependent chromatin remodeling enzyme CHD8. Febs Letters. 584: 689-93. PMID 20085832 DOI: 10.1016/J.Febslet.2010.01.022  0.534
Show low-probability matches.